**No Ebola cases linked to the current Central African outbreak have reached the United States, and CDC assessments continue to rate the risk to the general public as low.** The Bundibugyo virus outbreak, declared a public health emergency of international concern by WHO in mid-May, has produced roughly 363 confirmed cases and 62 deaths in the Democratic Republic of the Congo plus 15 cases in Uganda as of early June. Strict U.S. entry restrictions implemented in May—rerouting travelers from affected countries to designated airports for enhanced screening, temporary bans on certain non-citizens, and quarantine protocols for exposed Americans abroad—combined with the virus’s requirement for direct contact with symptomatic patients’ bodily fluids, sharply limit importation risk. With only weeks remaining until June 30 and no confirmed U.S. transmissions despite ongoing surveillance, trader consensus aligns with official containment measures and epidemiological patterns observed in prior outbreaks.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado¿Caso de ébola en EE. UU. antes del 30 de junio?
¿Caso de ébola en EE. UU. antes del 30 de junio?
Sí
$234,393 Vol.
$234,393 Vol.
30 jun 2026
Sí
$234,393 Vol.
$234,393 Vol.
30 jun 2026
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the United States of America reported between market creation and June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed Ebola infection identified within U.S. territory will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution source for this market will be official government information (e.g., the CDC); however, an overwhelming consensus of credible reporting will also suffice.**No Ebola cases linked to the current Central African outbreak have reached the United States, and CDC assessments continue to rate the risk to the general public as low.** The Bundibugyo virus outbreak, declared a public health emergency of international concern by WHO in mid-May, has produced roughly 363 confirmed cases and 62 deaths in the Democratic Republic of the Congo plus 15 cases in Uganda as of early June. Strict U.S. entry restrictions implemented in May—rerouting travelers from affected countries to designated airports for enhanced screening, temporary bans on certain non-citizens, and quarantine protocols for exposed Americans abroad—combined with the virus’s requirement for direct contact with symptomatic patients’ bodily fluids, sharply limit importation risk. With only weeks remaining until June 30 and no confirmed U.S. transmissions despite ongoing surveillance, trader consensus aligns with official containment measures and epidemiological patterns observed in prior outbreaks.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the United States of America reported between market creation and June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed Ebola infection identified within U.S. territory will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution source for this market will be official government information (e.g., the CDC); however, an overwhelming consensus of credible reporting will also suffice.
Any active laboratory-confirmed Ebola infection identified within U.S. territory will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution source for this market will be official government information (e.g., the CDC); however, an overwhelming consensus of credible reporting will also suffice.
Mercado abierto: May 15, 2026, 3:04 PM ET
Volumen
$234,393Fecha de finalización
30 jun 2026Mercado abierto
May 15, 2026, 3:04 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the United States of America reported between market creation and June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed Ebola infection identified within U.S. territory will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution source for this market will be official government information (e.g., the CDC); however, an overwhelming consensus of credible reporting will also suffice.**No Ebola cases linked to the current Central African outbreak have reached the United States, and CDC assessments continue to rate the risk to the general public as low.** The Bundibugyo virus outbreak, declared a public health emergency of international concern by WHO in mid-May, has produced roughly 363 confirmed cases and 62 deaths in the Democratic Republic of the Congo plus 15 cases in Uganda as of early June. Strict U.S. entry restrictions implemented in May—rerouting travelers from affected countries to designated airports for enhanced screening, temporary bans on certain non-citizens, and quarantine protocols for exposed Americans abroad—combined with the virus’s requirement for direct contact with symptomatic patients’ bodily fluids, sharply limit importation risk. With only weeks remaining until June 30 and no confirmed U.S. transmissions despite ongoing surveillance, trader consensus aligns with official containment measures and epidemiological patterns observed in prior outbreaks.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the United States of America reported between market creation and June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed Ebola infection identified within U.S. territory will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution source for this market will be official government information (e.g., the CDC); however, an overwhelming consensus of credible reporting will also suffice.
Any active laboratory-confirmed Ebola infection identified within U.S. territory will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution source for this market will be official government information (e.g., the CDC); however, an overwhelming consensus of credible reporting will also suffice.
Volumen
$234,468Fecha de finalización
30 jun 2026Mercado abierto
May 15, 2026, 3:04 PM ETResolver
0x65070BE91...**No Ebola cases linked to the current Central African outbreak have reached the United States, and CDC assessments continue to rate the risk to the general public as low.** The Bundibugyo virus outbreak, declared a public health emergency of international concern by WHO in mid-May, has produced roughly 363 confirmed cases and 62 deaths in the Democratic Republic of the Congo plus 15 cases in Uganda as of early June. Strict U.S. entry restrictions implemented in May—rerouting travelers from affected countries to designated airports for enhanced screening, temporary bans on certain non-citizens, and quarantine protocols for exposed Americans abroad—combined with the virus’s requirement for direct contact with symptomatic patients’ bodily fluids, sharply limit importation risk. With only weeks remaining until June 30 and no confirmed U.S. transmissions despite ongoing surveillance, trader consensus aligns with official containment measures and epidemiological patterns observed in prior outbreaks.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes